The Yamanaka Factors, also known as the OSKM factors, are a set of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) discovered by Shinya Yamanaka in 2006.
These factors have the remarkable ability to reprogram adult somatic cells into induced pluripotent stem cells (iPSCs), which resemble embryonic stem cells in their capacity to differentiate into various cell types.
This groundbreaking discovery has revolutionized regenerative medicine, offering significant implications for disease modeling, drug discovery, and potential cell-based therapies. The Yamanaka Factors have opened up new avenues for personalized medicine and sparked extensive research into understanding cellular reprogramming mechanisms.